Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01618799
Recruitment Status : Completed
First Posted : June 13, 2012
Last Update Posted : June 13, 2012
Information provided by (Responsible Party):
IPCA Laboratories Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2012
  Study Completion Date : May 2012